Oxidative stress as the triggering event for vascular remodelling

Paolo Silacci and Daniel Hayoz Division of Hypertension and Vascular Medicine, C H U V , Lausanne, Switzerland
Vascular remodelling is an important physiological process that takes place during embryogenesis as well as during adult life. In the adult, vascular remodelling is a necessary adaptive process in response to either modified haemodynamic conditions or to angioplasty. Chronic changes in blood flow and pressure induce adjustments that tend to maintain shear stress and wall stress constant [1] [2] [3] .
Vessel wall properties during remodelling
New non-invasive methodology that allows measurement of geometrical and mechanical properties of arteries, led to the characterization of vascular remodelling in animal models as well as in human hypertension. High resolution echotracking devices can be used to assess the biomechanical consequences of vascular remodelling. Using these devices an autoregulation of the mechanical properties of conduit vessels in the forearm of hypertensive patients as well as in the larger conduit vessels of hypertensive rat strains has been observed [2, 3] . Only Young's elastic modulus appeared to be modified during hypertension [3] , implying that the normalization of the circumferential wall stress is achieved by increased wall tissue mass. The thickened wall initially retains the same intrinsic properties as those of normotensive controls. However, over time the wall tissues become stiffer, as reflected by the increased incremental elastic modulus-stress relationship [3] .
Arterial wall remodelling involves thickening of the media, a process sustained by smooth muscle cells (SMCs) that undergo phenotype modulation to an activated state with increased migration and proliferative properties and that synthesize more extracellular matrix [4, 5] . Therefore, in addition to the direct effects of mechanical forces on putative mechanoreceptors, other deleterious triggering mechanisms can contribute to vascular wall remodelling that ultimately predisposes to atherosclerosis.
Wall constituants respond to mechanical forces to reach a new steady state, mainly via wall thickening. However, this compensatory event may indeed perpetuate some of the triggering mechanisms that induce stiffening of the artery.
The biochemical nature of the trigger for remodelling
One of the key factors contributing to vessel wall homeostasis is nitric oxide (NO) which is synthesized during the conversion of L-arginine to L-citrulline in a reaction catalysed by an NO synthase enzyme. Endothelial cells express a constitutive form of this enzyme (NOS III) which can be modulated by mechanical forces [6] . NO is an important mediator that controls vascular tone via a cGMP-dependent signalling pathway leading to tyrosine nitration of contractile proteins in SMCs [7] [8] [9] [10] . When present at high concentrations, NO can also induce apoptosis via a cGMPindependent pathway [11, 12] . Moreover, NO is a scavenger molecule for a superoxide anion with which it reacts to form peroxynitrites (ONOO") another reactive oxygen species with high cytotoxic effects [11, 12] . Thus, the NO concentration in tissues results from the balance between synthesis and scavenging rates.
The role of oxidative stress-the equilibrium between NO and reactive oxygen species
Recent results, obtained in our laboratory suggest that an increased oxidative stress may represent a triggering event for vessel wall thickening during hypertension. Indeed, in a rat model of renovascular hypertrophy (two kidney-one clip), an increased net production of superoxide anion has been detected at 2 and 24 weeks after clipping, concomitant with vascular wall thickening [3] .
Both during hypertension and atherosclerotic plaque development, the equilibrium between NO and reactive oxygen species seems to be disturbed [12] [13] [14] . In both cases an increased scavenging rate by the superoxide anion is observed without changes in NO synthesis rate. Moreover, an increased superoxide anion production has been observed in angiotensin II-induced hypertension via a membrane-bound NADH/NADPH oxidase activity, but not in cathecolamines-induced hypertension [15] [16] [17] . Furthermore, the NADH/ NADPH oxidase has been shown to regulate the angiotensin II-induced hypertrophy in SMCs [18] . Evidence for the role of the scavenging rate is provided by the observation that in patients with essential hypertension, sodium nitroprusside-dependent vasodilatation is increased by the administration of copperzinc superoxide dismutase [19] . All these observations suggest that the imbalance between NO and reactive oxygen species plays a pivotal role in sustaining elevated blood pressure. On the other hand, cytokine stimulation of cells results in induction of inducible NO synthase (NOS II) expression and increased oxidative stress [20, 21] . The consequent increased NO and ONOO" production is responsible for the loss of cellular respiratory capacity by covalently modifying haeme-containing enzymes, and is also responsible of the contractility of arteries [22] [23] [24] . These effects are probably partially mediated by the activation of polyADP ribosyl synthase (PARS), an enzyme which induces DNA strand breakage [25, 26] . Moreover, NO donor stimulation of different cell types including SMCs, induces apoptosis by a cGMP-independent pathway [10] .
Cross-talk between NO and VEGF?
Until now, involvement of an oxidative stress as a triggering event for arterial wall remodelling has not been definitively demonstrated. However, new evidences suggest the existence of a cross-talk between NO and VEGF/VPF (vascular endothelial growth factor/ vascular permeabilizing factor). In response to increased oxidative stress, VEGF synthesis is enhanced [27, 28] . VEGF was shown to down-regulate NO production in organ culture [29] . In a recent experiment performed in our laboratory, we were able to show that VEGF is expressed in bovine aortic endothelial cells when these are cultured in static condition, and NOS III expression is down-regulated to undetectable levels. However, when mechanical forces are applied to endothelial cells, in order to expose them to an environment mimicking in vivo flow conditions, VEGF expression is down-regulated, while NOS III is up-regulated [30] . Therefore, it appears that under normal physiological conditions, endothelial cells are exposed to mechanical forces that maintain NO production within normal levels. Dysfunction of the endothelium can alter NO bioavailability via an increased oxidative state and consequently increase VEGF expression resulting in increased vascular permeability. This in turn leads to SMCs exposition to factors that may modulate their phenotype. The cumulative effects of mechanical forces and oxidative stress may also partly up-regulate manganese superoxide dismutase [31] [32] [33] . This enzyme plays an important antioxidative role in cells, reducing the level of reactive oxygen species. In essential hypertension, superoxide dismutase in erythrocytes is decreased [34] , providing in vivo evidence that this enzyme could be an important element in disrupting the balance between NO and the reactive oxygen species, therefore maintaining an elevated blood pressure level.
Hypothesis concerning the pathogenic sequence
In conclusion, a reduction of NO bioavailability by superoxide anions, combined with a direct negative effect of blood pressure on superoxide dismutase, may contribute to the perpetuation of elevated blood pressure. This may be especially evident in plaque-prone regions where the mean blood flow is ~ 0. It is conceivable to hypothesize that during hypertension the oxidative stress, to which cells are exposed, increases to a much greater extent in these plaque-prone regions than in high shear stress zones where NO is available. This could be due to a down-regulation of NOS III and superoxide dismutase expression by a mean blood flow near to zero with consequent decreased NO production and increased superoxide anion concentrations. The ensuing endothelial dysfunction associated with increased concentrations of VEGF results in increased vascular permeability that may participate in the induction of vascular wall remodelling and possibly atherosclerosis.
Introduction
Goodpasture syndrome is the most common manifestation (60%) of human anti-basement membrane diseases, characterized by the presence of autoantibodies that predominantly recognize the non-collagenous (NCI) domain of the alpha 3 chain of basement membrane (type IV) collagen. The clinical manifestation of Goodpasture syndrome is a rapidly progressive glomerulonephritis and pulmonary haemorrhage, but anti-basement membrane disease can also occur as glomerulonephritis without lung involvement (35%), or as isolated pulmonary haemorrhage (<5%). For reasons summarized in the citation above, Goodpasture syndrome, despite its low incidence, has drawn widespread attention over almost 80 years of research history.
Pathogenesis
The cause of the disease is unknown. Smoking, inhalation of gasoline or other hydrocarbon fumes, as well as viral respiratory infections have been implicated to promote the disease by causing injury to the basement membrane where the antigenic epitope resides in the type IV collagen network. It seems possible that increased quantities of the cryptic epitope thus become exposed to the immune system, triggering an autoimmune response. The disease association with HLA DR2 and DR4 haplotypes implies a genetic susceptibility [2] . There is evidence of T-cell involvement in the autoimmune response, as NCI-specific CD4 and CD8 T cells have been isolated from patients in early and late phases of Goodpasture syndrome, respectively [3, 4] . The autoantibodies are predominantly of the IgGl subtype, and in active disease they may represent up to 1% of total serum IgG [5] . Antibody deposition in the basement membrane is often, but not always accompanied by complement, promoting autoimmune inflammatory damage in those regions where alpha 3 (IV) is expressed and accessible. Serum antibody titres correlate with active disease, but not necessarily with the degree of inflammatory tissue damage and impairment of renal function, or the severity of lung hemorrhage.
Course and prognosis
If left untreated, the course of Goodpasture syndrome is usually fatal. Since the 1970s, a combined therapy with plasmapheresis and immunosuppression has led to a much improved survival. The pulmonary complications usually resolve and do not have much impact on long-term pulmonary function [6] . However, the glomerulonephritis results in terminal renal failure in ~70%. The renal outcome can be predicted from the serum creatinine and the fraction of glomeruli with crescents at the time of presentation [1, 7, 8] . Patients with creatinine values > 600 umol/1 or > 50% crescents at renal biopsy can rarely be expected to retain independent renal function. Early diagnosis and immediate institution of therapy are the only way to improve the dismal renal outcome in Goodpasture syndrome.
